Potency test in 4 h
Accelerate decision making from bench to bedside
Immunotherapy success depends on how cells recognize, engage, and eliminate targets. Yet, standard functional testing still relies on slow, indirect assays that delay critical decisions from discovery to clinic.
SpectaCell removes this bottleneck.
Advantages
Immunotherapies are living medicines.
Their behavior matters.
Breaking through the analytical silo’s within the development funnel
We deliver faster functional insights at the single-cell level to accelerate therapy development and patient access.
Advantages
SpectaCell introduces a behavior-based approach to potency testing
Breaking through the analytical silo’s within the development funnel
Observe cellular interactions in real time
Capture behavior linked to therapeutic performance
Instead of relying only on endpoint readouts, SpectaCell captures thousands of live cell interactions in real time.
Turn complex cell dynamics into actionable insights
Lead ID & process development
Clinical manufacturing QC
Understand mode of action
Speed up lead ID
Fine tune product & process
Get robust, deep data
Stackable, single sample QC
Release the same day
Cell dynamics based potency
No labels, no prep
Technology
Providing one tool to accelerate cell therapies
Our unique platform enables robust, fast characterization of cell therapies throughout R&D and clinical manufacturing stages. It's one platform for all, allowing researchers, developers and manufacturers to better predict potency of therapies, improving efficiency and time to market.
The next-gen potency test for cell therapies
Advantages
VACANCIES
Join Spectacell
Breaking through the analytical silo’s within the development funnel
Help us turn live cell behavior into insights that accelerate patient access to cell therapies.
We'll make cell-based testing so fast, simple & reliable that next-gen immunotherapies reach all eligible patients
Now hiring:
The SpectaCell™ platform captures dynamic cell behavior, for a faster, deeper, and simpler path to advance CAR-T and other therapies.
Mass parallel, single cell depth
Combines 10,000+ cell-cell interactions per run for unrivalled statistical power
Real time, label free
Detect behavior cytomic events in real-time
Compact, easy to integrate
Stackable instrument keeps footprints small and supports random access workflows
Advantages
One platform
from discovery to release
Breaking through the analytical silo’s within the development funnel
Advantages
One platform from discovery to release
Breaking through the analytical silo’s within the development funnel
Potency test in 4 h
Accelerate decision making from bench to bedside
Mass parallel, single cell depth
Combines 10,000+ cell-cell interactions per run for unrivalled statistical power
Real time label free
Detect behavior cytomic events in real-time
Compact, easy to integrate
Stackable instrument keeps footprints small and supports random access workflows
Problem
Current potency testing slows
access to cell therapy
New cancer treatments hold great promise, yet progress is slow and approvals stall because data are trapped in silo’s along the drug development.
Redefining potency testing through behavior cytomics
Lens-free imaging & AI analytics tracks morphological & kinetic changes at single cell resolution
The micro-compartimentalized cartridge pairs effector and target cells to capture thousands of killing events
The hybrid data engine provides secure analytics for deeper insight & audit trail
Backed by
Technology built on
decades of expertise
We combine a decade of advances in nano- and digital technologies with cell biology to solve analytical bottlenecks in drug development and manufacturing.